Author:
Vijayalingam S,Kuppuswamy M,Subramanian T,Strebeck F F,West C L,Varvares M,Chinnadurai G
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Molecular Biology,Molecular Medicine
Reference44 articles.
1. 1. Ries L, Young J, Keel G, Eisner M, Lin Y, Horner M SEER Survival Monograph: Cancer Survival Among Adults: US SEER Program 1998-2001, Patient and Tumor Characteristics. National Cancer Institute, SEER Program
2. 2. NIH Pub. No. 07-6215: Bethesda, MD, 2007.
3. Huang SM, Bock JM, Harari PM . Epidermal growth factor receptor blockade with C225 modulates proliferation, apoptosis, and radiosensitivity in squamous cell carcinomas of the head and neck. Cancer Res 1999; 59: 1935–1940.
4. Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 2006; 354: 567–578.
5. Baselga J, Schoffski P, Rojo F, Dumez H, Ramos FJ, Macarulla T et al. A phase I pharmacokinetic (PK) and molecular pharmacodynamic (PD) study of the combination of two anti-EGFR therapies, the monoclonal antibody (MAb) cetuximab (C) and the tyrosine kinase inhibitor (TKI) gefitinib (G), in patients (pts) with advanced colorectal (CRC), head and neck (HNC) and non-small cell lung cancer (NSCLC). J Clin Oncol 2006; 24: 122s–122s.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献